IP Verse

Amgen vs. Alexion Pharmaceuticals - APP_3053/2025

The case APP_3053/2025 was filed by the plaintiff Amgen against the defendant Alexion Pharmaceuticals on 21 Jan, 2025.

Case Timeline

21 Jan, 2025
Case Filed
02 Oct, 2025
Written Procedure
Today Nov 1, 2025
Oral Procedure
Decision

Case Details

    Case Number:

    APP_3053/2025

    Patent Number:

    EP3167888

    Filing Date:

    21 Jan, 2025

    Proceeding Type:

    Generic

    Case Phase:

    Written Phase

    Plaintiffs:

    • Amgen

    Plaintiff Representative:

    • Tilman Mueller-Stoy

    Defendants:

    • Alexion Pharmaceuticals

    Defendant Representative:

    • Elena Hennecke

    Judges:

    • Alima Zana
    • Rudi Goedeweeck
    • Sabine Klepsch
    • Stefan Schilling

    Court Division:

    First Instance, Local Division - Hamburg

Case Decision

Decision pending - set alert to receive updates

Docket Entries

The docket entries provide a comprehensive overview of all filings, motions, orders, and other significant actions taken in the case.

Last updated on: Oct 30, 2025
DateTitle

Notify me when new UPC document is filed

Oct 8, 2025Order
Oct 8, 2025Action.Issueorder
Oct 2, 2025Receipt
Oct 2, 2025Other Document
Oct 2, 2025Cover Sheet
Sep 17, 2025Rectification
Sep 17, 2025Outcome Of The Order
Sep 10, 2025Receipt
Sep 10, 2025Outcome Of The Order
Sep 10, 2025Deadline Extension
Sep 9, 2025Deadline Extension Request
Sep 9, 2025Application For Rectification Ord 35478 2025
Sep 9, 2025262.2 Application
Sep 4, 2025Outcome Of The Order
Sep 4, 2025Order With Grounds
Sep 4, 2025Anhoerung
Sep 3, 202520250903 Second Instance Costs Confidentiality Reply Amgen Signed
Aug 31, 2025Anhoerung
Aug 28, 2025Comments
Aug 25, 2025Anhoerung
Aug 21, 2025Receipt
Aug 20, 2025Exhibit Bp Kf01 Amgen 3053 2025
Aug 20, 202520250820 Second Instance Costs Reply Amgen 3053 2025 Confidential Signed
Aug 20, 202520250820 Confidentiality Applications 262 2 262 A Second Instance Costs Amgen Signed
Aug 6, 2025Anhoerung
Jul 14, 2025Comments
Jul 2, 2025Anhoerung
Jan 21, 2025Receipt
Jan 20, 2025Application

More cases involving EP3167888B1

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
UPC_CFI_674/2025Jul 22, 2025Samsung Bioepis NLAlexion Pharmaceuticals
UPC_CFI_51/2025Jan 23, 2025Samsung Bioepis NLAlexion Pharmaceuticals
UPC_CFI_40/2025Jan 22, 2025Samsung Bioepis NLAlexion Pharmaceuticals

More cases involving Amgen

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_35200/2025Aug 21, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
APP_35086/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -
APP_35087/2025Aug 20, 2025Amgen, Amgen AB, Amgen Biofarmaceutica LDA, Amgen Technology Ireland Unlimited, Amgen Zdravila DOO -

More cases involving Alexion Pharmaceuticals

This table lists the related cases associated with the patent, including case numbers, plaintiffs, and defendants involved in each case.

Last updated on: Oct 30, 2025
Case NumberFiling DatePlaintiffsDefendants
APP_35353/2025Aug 22, 2025Alexion Pharmaceuticals -
ORD_35357/2025Aug 22, 2025Samsung BioepisAlexion Pharmaceuticals
APP_35118/2025Aug 20, 2025Alexion Pharmaceuticals -